Iwona Pawlikowska-Dobler
0000-0001-5911-852X
Takeda Pharmaceuticals USA Inc
2 papers found
Refreshing results…
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
Missing publications? Search for publications with a matching author name.